When was Neurosynaptic founded?

Neurosynaptic was founded in 2002 and raised its 1st funding round 4 years after it was founded.

Where is Neurosynaptic located?

Neurosynaptic is headquartered in Bengaluru, India. It is registered at NO. 48/2, SULAPPA TOWER, DODDANAGAMANGALA, ELECTRONIC CITY POST, Bangalore, BANGALORE, Karnataka, India, 560100.

Who is the current CEO of Neurosynaptic?

Sameer Subhash Sawarkar of Neurosynaptic. They have also founded 1 company.

Which legal entities is Neurosynaptic associated with?

Neurosynaptic is associated with NEUROSYNAPTIC COMMUNICATIONS PRIVATE LIMITED and 1 other.

How many employees does Neurosynaptic have?

As of Nov 30, 2024, the latest employee count at Neurosynaptic is 29.

Is Neurosynaptic a funded company?

Neurosynaptic is a funded company, having raised a total of $1.61M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 24, 2006.

How much is Neurosynaptic worth?

The latest valuation of Neurosynaptic is ₹***** as of Sep 30, 2020.

When was the latest funding round of Neurosynaptic?

Neurosynaptic's latest funding was a $***** Series A round on Sep 30, 2020, with participation from 7 investors.

What is the annual revenue of Neurosynaptic?

Annual revenue of Neurosynaptic is ₹9.78Cr as on Mar 31, 2025.

Where does Neurosynaptic rank among its competitors?

Neurosynaptic ranks 4th amongst 130 active competitors, of which 28 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Allos Global, which secured $5M in Jan, 2026.

Who are the top competitors of Neurosynaptic?

Neurosynaptic's top competitors include Neko Health, numares and MY01. Among them, Allos Global secured the most recent funding round in January, 2026.

Neurosynaptic - 2026 Company Profile, Team, Funding, Competitors & Financials

Neurosynaptic is a series A company based in Bengaluru (India), founded in 2002 by Sameer Subhash Sawarkar and Rajeev Kumar. It operates as a Developer of ICT based products and solutions for healthcare industry. Neurosynaptic has raised $1.61M in funding from investors like Ventureast, KOIS and e-Zest, with a current valuation of ₹*****. The company has 130 active competitors, including 28 funded and 5 that have exited. Its top competitors include companies like Neko Health, numares and MY01.

Company Details

Neurosynaptic is a healthcare technology involved in the development of ICT-based products. The company developing a diagnostic kit - ReMeDi for medical data storage and access and comprising of products such as ECG, stethoscope, temperature measuring, oximeter, etc. The professional edition provides patient and doctor application software which is cloud-based and enables remote consultation. Its enterprise edition comprises of server application along with patient and doctor-client applications offering multiple features. The company claims that its flagship platform, ReMeDi has been deployed in 1600 operational health centers in several developing countries and reaches 50 million people.

Website: neurosynaptic.com
Social
Email ID: *****@neurosynaptic.com
Phone Number: +91 **********
Registered Address: NO. 48/2, SULAPPA TOWER, DODDANAGAMANGALA, ELECTRONIC CITY POST, Bangalore, BANGALORE, Karnataka, India, 560100

Key Metrics

Founded Year

2002

Location

Bengaluru, India

Stage

Series A

Total Funding

$1.61M in 6 rounds

Latest Funding Round

Series A, Sep 30, 2020, $*****

Post Money Valuation

₹***** as on Sep 30, 2020

Investors

Ventureast & 64 more

Ranked

4^th among 130 active competitors

Annual Revenue

₹9.78Cr as on Mar 31, 2025

Employee Count

29 as on Nov 30, 2024

Similar Companies

Neko Health & 107 more

View Neurosynaptic's full profile

Neurosynaptic is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
JYKO LIMITED CIN: 14292483 , United Kingdom, Active	Aug 11, 2022	$65.8K (As on Aug 31, 2025)	1 (As on Aug 31, 2025)
NEUROSYNAPTIC COMMUNICATIONS PRIVATE LIMITED CIN: U73100KA2002PTC031023 , India, Active	Sep 20, 2002	$1.16M (As on Mar 31, 2025)	29 (As on Nov 30, 2024)

Neurosynaptic has raised a total funding of $1.61M over 6 rounds. Its first funding round was on Jul 24, 2006. Its latest funding round was a Series A round on Sep 30, 2020 for $*****. 7 investors participated in its latest round. Neurosynaptic has 24 institutional investors and 41 angel investors.

Here is the list of recent funding rounds of Neurosynaptic:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 30, 2020	5115415	Series A	9125632	8871714	9820471	6841794
May 12, 2019	8472383	Series A	7262059	3890716	6742550	JSA
Sep 26, 2016	1839584	Series A	3560392	8334575	HealthQuad	Prakash VGN & 51 more

Access funding benchmarks and valuations. Sign up today!

View details of Neurosynaptic's funding rounds and investors

The founders of Neurosynaptic are Sameer Subhash Sawarkar and Rajeev Kumar. Sameer Subhash Sawarkar is the CEO of Neurosynaptic.

Here are the details of Neurosynaptic's key team members:

Sameer Subhash Sawarkar: Co-Founder & CEO of Neurosynaptic. They serve on the board of 1 company.
Contact Info: 1 email address
Rajeev Kumar: Co-Founder & COO of Neurosynaptic. They serve on the board of 1 company.
Contact Info: 1 email address

Neurosynaptic's Board of Directors

Neurosynaptic's board has 2 active members. Sameer Subhash Sawarkar and Rajeev Kumar are part of team.

Here is the list of Neurosynaptic's board of directors:

Name	Type	Representing	Status	Duration
Sameer Subhash Sawarkar	Team	-	Current	23y 5m
Rajeev Kumar	Team	-	Current	22y 2m
ypnxlue	Independent board member	-	Past	9y 5m

View details of Neurosynaptic's Founder profiles and Board Members

Neurosynaptic's employee count trend

Neurosynaptic has 29 employees as of Nov 24. The total employee count is 7.0% more than what it was in Nov 23. Here is Neurosynaptic's employee count trend over the years:

Uncover Neurosynaptic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neurosynaptic include Neko Health, numares and MY01. Here is the list of Top 10 competitors of Neurosynaptic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neko Health 2018, Stockholm (Sweden), Series B	Platform offering solutions for preventive health scans	$325M	Lightspeed Venture Partners, Lakestar & 3 others	61/100
2nd	numares 2004, Regensburg (Germany), Series B	Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy	$26.8M	Bayern Kapital, Kfw & 2 others	57/100
3rd	MY01 2015, Singapore (Singapore), Series A	AI-powered medical device for the detection of compartment syndrome	$12.6M	Invest Quebec, Antler & 4 others	54/100
4th	Neurosynaptic 2002, Bengaluru (India), Series A	Developer of ICT based products and solutions for healthcare industry	$1.61M	Texport Industries, Momentum & 63 others	53/100
5th	IR-MED 2012, Rosh Pinna (Israel), Public	Developer of non-invasive devices for real-time biomarker analysis of blood and tissue	$2.21M	Innovation Israel	52/100
6th	Allos Global 2021, Berkeley (United States), Seed	AI-powered decision support tools for diagnosing autoimmune diseases	$5M	Oxford Science Enterprises, SV Health Investors ... & 2 others	49/100
7th	FemDx Medsystems 2020, Santa Clara (United States), Series A	Provider of a medical diagnostic tool for healthcare providers	$3.5M	ShangBay Capital, SV Tech Ventures & 1 others	45/100
8th	WuXi Diagnostics 2018, Rochester (United States), Series B	Provider of solution for diagnosis of disease for healthcare providers	$200M	Yunfeng Capital, CCB International & 5 others	44/100
9th	NuvoAir 2015, Stockholm (Sweden), Series A	Provider of clinical decision support tools for respiratory diseases	$28.1M	Hikma Ventures, Industrifonden & 5 others	44/100
10th	ANAsens 2020, Montreal (Canada), Funding Raised	Provider of COVID-19 point-of-care diagnostic platform	-	Centech	43/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Neurosynaptic's competitors? Click here to see the top ones

Founders (largest shareholder) own 53.70%, Funds own 16.62%, Enterprises own 11.02% and Angels own 11.72%. The net worth of Neurosynaptic's founders is INR 14.8Cr as of Sep 30, 2020.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	53.70%	14.8Cr	7857127	1051045	2820565	3162671
Sameer Subhash Sawarkar	1130041	1817580	4794804	8852943	5553106	4642628
Rajeev Kumar	4993875	2322119	9109778	4004233	2252048	5386625
Fund	16.62%	4.57Cr	2556194	2923594	6292894	3296137
KOIS	2	6	6	8	7	1
HealthQuad	2304598	5063689	3625621	7477973	7313916	3949610
Enterprise	11.02%	3.04Cr	3642039	5114418	1661375	4237622
Angel	11.72%	3.23Cr	8246707	4568287	3842896	3130731
Nagaraja Prakasam	7	2	6	7	4	1
Sunil Kant Munjal	0	0	0	0	0	0
Prakash VGN	0	0	0	0	0	0
ESOP Pool	6.94%	1.91Cr	173199	763980	228760	816628
Total	100.00%	27.5Cr	5381981	6329255	1041464	7245415